UNSPSC 41131729: Sickle cell test

In this classification a sickle cell test is a device used to determine the sickle cell hemoglobin content of human blood to detect sickle cell trait or sickle cell diseases US FDA regulates Sickle cell test under 21 CFR 864.7825 and under FDA product code GHM.

UNSPSC 41131729 Sickle cell test is a Commodity code under which state and local governments procure drug and substance-testing supplies, reagents, collection kits, and related laboratory consumables to support criminal justice, occupational health, forensic, and clinical laboratory operations. The code's scope diverges significantly from its nominal title; recent opportunities show state and local agencies buying specimen collection services, drug-screening panels, urinalysis testing, naloxone and drug deactivation supplies, forensic reference materials and assay kits, and occupational medical health screening rather than sickle cell diagnostics specifically. Issuing bodies span county criminal justice and community supervision departments, county health care services, city public safety and human resources operations, county and state forensic laboratories, occupational health programs, and state health agencies. Collin County Commissioners Court, Gwinnett County, the Texas Comptroller of Public Accounts Statewide Procurement Division, and Pinellas County appear multiple times across the recent opportunities, indicating steady demand from Texas jurisdictions and select Florida and Georgia counties.

Geographic activity concentrates in Texas (Collin County, Texas Comptroller), Georgia (Gwinnett County), Florida (Seminole County, Pinellas County), Oregon (Benton County, State of Oregon), and North Carolina (Charlotte). Representative recent opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services at two sites with approximately 25,031 tests annually under a two-year contract (estimated value $600,000, proposals due July 23, 2026); Benton County's solicitation for urinalysis testing services for the Family Treatment Court Program requiring twice-weekly testing with secure web-based reporting (proposals due July 7, 2026); the Texas Comptroller's IFB 304T-27-175A1.1 for proprietary forensic laboratory consumables and drug-screening reagents across 50 line items from Life Technologies, Promega, Qiagen, Immunalysis, and ANDE Corporation (bids due October 20, 2026); and Pinellas County's procurement of certified drug reference standards for forensic laboratory validation funded through the Paul Coverdell Forensic Sciences Improvement Act Program with $49,034.00 designated for supplies (proposals due April 23, 2026).